Clinical Trials Sponsored by National Blood Center Foundation, Hemolife

Total 2027 results

National Heart, Lung, and Blood Institute (NHLBI)

Completed

Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine

Healthy Volunteers

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Biomarkers for Cardiovascular Disease

Coronary Artery Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy (HCM)

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluation of Patients With Known or Suspected Heart Disease

Heart Failure | Coronary Disease | Pulmonary Hypertension | Peripheral Artery Disease | Dilated Cardiomyopathy | Renal Artery Stenosis | Diabetes and Heart Failure

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Coated Endotracheal Tube and Mucus Shaver to Prevent Hospital-Acquired Infections

Infection

Italy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis

Rheumatoid Arthritis | Pulmonary Fibrosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants

Coronary Artery Disease (CAD)

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Nitrite Infusion Studies

Healthy

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of TNFR:Fc (Enbrel) in the Treatment of Asthma

Asthma

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Technical Development of Strain Rate Echocardiography

Echocardiography, Doppler

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Regular Exercise on Vascular Function and Cardiovascular Risk in a Sedentary Work Force

Vascular Formation

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Tissue Collection From People With Cystic Fibrosis

Cystic Fibrosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Imaging of Totally Blocked Arteries

Atherosclerosis | Intermittent Claudication | Peripheral Artery Disease | Chronic Total Aterial Occlusion

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Magnetic Resonance Imaging at Different Levels of Magnetic Intensity

Healthy | Cardiovascular Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop...

Hypertrophic Cardiomyopathy

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia

Refractory Chronic Lymphocytic Leukemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Rosiglitazone to Reverse Metabolic Defects in Diabetes

Insulin Resistance | Diabetes Mellitus, Type II

United States
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress

Ischemic Stress | Transient Non-Lethal Ischemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Validation of MRI Measurement of Cardiac Blood Flow

Coronary Artery Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Decitabine for High-Risk Sickle Cell Disease

Neutropenia | Sickle Cell Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

Lymphoma | Lymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Leukemia | Leukemia, Myeloid | Hodgkin Disease | Leukemia, Myelomonocytic, Chronic | Graft vs Host Disease | Leukemia, Lymphocytic | Lymphoma, Mantle-cell

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors

Cytomegalovirus Infections

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy

Myelodysplastic Syndrome | Acute Myeloid Leukemia (AML) | Chronic Myeloid Leukemia (CML)

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Ascites | Lymphangioleiomyomatosis | Lymphangiomyomas | Pleural Effusions

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia

Chronic Myeloid Leukemia | Graft vs Host Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Quality Control of Cardiopulmonary Exercise Equipment

Healthy

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluation and Treatment of Heart Disease in Patients Not Participating in Research

Arrhythmia | Heart Disease | Congenital Heart Defect

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparing Treatments for Multiple Myeloma

Multiple Myeloma

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Diagnosis and Treatment of Pheochromocytoma

Pheochromocytoma

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Treatment of Pulmonary Sarcoidosis With Pentoxifylline

Pulmonary Sarcoidosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Immune Response to Cytomegalovirus

Cytomegalovirus Infections

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Hemoglobinuria

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluation of Left Ventricular Volumes by Real-Time 3-Dimensional Echocardiography

Heart Diseases

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia

Diamond Blackfan Anemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease

Cardiomyopathy, Hypertrophic, Familial

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction

Coronary Disease | Arterial Occlusive Diseases | Atherosclerosis | Cytomegalovirus Infections

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease

Coronary Artery Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals

Lung Diseases, Obstructive | Emphysema | Alpha 1-Antitrypsin Deficiency

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of the Effects of Temperature on Metabolism in Human Muscle

Healthy

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme

Coronary Disease | Atherosclerosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

Coronary Disease | Atherosclerosis | Vasculitis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Atherosclerosis in the Coronary and Carotid Arteries

Coronary Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Blood Flow in Heart Muscle

Myocardial Ischemia | Coronary Disease | Healthy | Hypertrophic Cardiomyopathy

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Lymphoma | Myelodysplastic Syndromes | Myeloid Leukemia | Hematologic Neoplasms | Graft vs Host Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections

Atherosclerosis | Pneumonia, Bacterial | Cytomegalovirus Infections | Chlamydia Infections | Postmenopause

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients With Coronary Artery Disease

Myocardial Ischemia | Coronary Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy

Cardiomyopathy, Hypertrophic

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Nitrite on Blood Vessel Dilation in Normal Volunteers

Healthy | Nitric Oxide | Endothelium-Derived Relaxing Factor

United States

Clinical Trials Sponsored by National Blood Center Foundation, Hemolife

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations